The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
LHRH-Targeted Nanogels as a Delivery System for Cisplatin to Ovarian Cancer
Open accessAbstract
Targeted drug delivery using multifunctional polymeric nanocarriers is a modern approach for cancer therapy. Our purpose was to prepare targeted nanogels for selective delivery of chemotherapeutic agent cisplatin to luteinizing hormone-releasing hormone (LHRH) receptor overexpressing tumor in vivo. Building blocks of such delivery systems consisted of innovative soft block copolymer nanogels with ionic cores serving as a reservoir for cisplatin (loading 35%) and a synthetic analogue of LHRH conjugated to the nanogels via poly(ethylene glycol) spacer. Covalent attachment of (D-Lys6)-LHRH to nanogels was shown to be possible without loss in either the ligand binding affinity or the nanogel drug incorporation ability. LHRH-nanogel accumulation was specific to the LHRH-receptor positive A2780 ovarian cancer cells and not toward LHRH-receptor negative SKOV-3 cells. The LHRH-nanogel cisplatin formulation was more effective and less toxic than equimolar doses of free cisplatin or untargeted nanogels in the treatment of receptor-positive ovarian cancer xenografts in mice. Collectively, the study indicates that LHRH mediated nanogel-cisplatin delivery is a promising formulation strategy for therapy of tumors that express the LHRH receptor.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Successful targeted delivery of these drug-loaded micelles to the tumors using tumor-specific ligands attached to the micelle outer PEG chains were also described [179–181].”
From Polymeric micelles for the delivery of poorly soluble drugs: From nanoformulation to clinical approval. (2020) · cites this paper as [180]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Mosmann, T. (1983) · Journal of Immunological Methods · doi:10.1016/0022-1759(83)90303-4 · Cited by 56,104
Tumor vascular permeability and the EPR effect in macromolecular therapeutics: a review
Maeda, H., Wu, J., Sawa, T., Matsumura, Y., & Hori, K. (2000) · Journal of Controlled Release · doi:10.1016/s0168-3659(99)00248-5 · Cited by 6,565
Nanoparticle therapeutics: an emerging treatment modality for cancer
Davis, M. E., Chen, Z., & Shin, D. M. (2008) · Nature Reviews Drug Discovery · doi:10.1038/nrd2614 · Cited by 4,233
Strategies in the design of nanoparticles for therapeutic applications
Petros, R. A., & DeSimone, J. M. (2010) · Nature Reviews Drug Discovery · doi:10.1038/nrd2591 · Cited by 3,651
The dawning era of polymer therapeutics
Duncan, R. (2003) · Nature Reviews Drug Discovery · doi:10.1038/nrd1088 · Cited by 3,269
Nanomedicine: current status and future prospects
Moghimi, S. M., Hunter, A. C., & Murray, J. C. (2005) · The FASEB Journal · doi:10.1096/fj.04-2747rev · Cited by 2,029
TORCHILIN, V (2006) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2006.09.009 · Cited by 1,273
Low, P. S., Henne, W. A., & Doorneweerd, D. D. (2008) · Accounts of Chemical Research · doi:10.1021/ar7000815 · Cited by 1,173
Arany, I., & Safirstein, R. L. (2003) · Seminars in Nephrology · doi:10.1016/s0270-9295(03)00089-5 · Cited by 906
Schally, A. V., Arimura, A., Kastin, A. J., Matsuo, H., Baba, Y., Redding, T. W., Nair, R. M. G., Debeljuk, L., & White, W. F. (1971) · Science · doi:10.1126/science.173.4001.1036 · Cited by 770
Research works printed but not linked: 2
- Oberoi H. S., 2012, Chemother. Res. Pract., 2012, 905796
- Segal E., 1985, Cancer Res., 45, 492
Cited by
Hwang, D., Ramsey, J. D., & Kabanov, A. V. (2020) · Advanced drug delivery reviews · doi:10.1016/j.addr.2020.09.009 · Cited by 699
Self-citationNanogels: An overview of properties, biomedical applications and obstacles to clinical translation
Soni, K. S., Desale, S. S., & Bronich, T. K. (2016) · Journal of Controlled Release · doi:10.1016/j.jconrel.2015.11.009 · Cited by 683
“folate or LHRH peptide), tumor growth inhibition could be even further enhanced [85,86,97].”
BackgroundSelf-citationRecent Advances in Nanoparticle-Based Cancer Drug and Gene Delivery
(2018) · Advances in Cancer Research · doi:10.1016/bs.acr.2017.11.003 · Cited by 288
“These nanogels were less toxic and showed enhanced antitumor activity (Nukolova et al., 2013).”
BackgroundNanogels for delivery, imaging and therapy
Sivaram, A. J., Rajitha, P., Maya, S., Jayakumar, R., & Sabitha, M. (2015) · WIREs Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1328 · Cited by 173
Can nanomedicines kill cancer stem cells?
Zhao, Y., Alakhova, D. Y., & Kabanov, A. V. (2013) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2013.09.016 · Cited by 137
Self-citationLi, M., Tang, Z., Zhang, Y. X., Lv, S., Li, Q., & Chen, X. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.02.022 · Cited by 117
Polymeric biomaterials for the delivery of platinum-based anticancer drugs
Kim, J., Pramanick, S., Lee, D., Park, H., & Kim, W. J. (2015) · Biomaterials Science · doi:10.1039/c5bm00039d · Cited by 102
Reduction-responsive polypeptide nanogel delivers antitumor drug for improved efficacy and safety
Huang, K., Shi, B., Xu, W., Ding, J., Yang, Y. Z., Liu, H., Zhuang, X., & Chen, X. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.08.049 · Cited by 93
Tambe, P., Kumar, P., Paknikar, K. M., & Gajbhiye, V. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s184634 · Cited by 77
“52% of breast cancer cells and 86% of prostate cancer cells overexpress gonadotropin-releasing hormone (GnRH) receptors.(15) These receptors act by recognizing GnRH (also known as luteinizing hormone-releasing hormone), which exerts a stimulatory effect on gonadotropin secretion, leading to their overexpression on can…”
BackgroundLHRH-Targeted Drug Delivery Systems for Cancer Therapy
Li, X., Taratula, O., Taratula, O. R., Schumann, C., & Minko, T. (2016) · Mini-Reviews in Medicinal Chemistry · doi:10.2174/1389557516666161013111155 · Cited by 77
Multifunctional platinum‐based nanoparticles for biomedical applications
Cheng, Q., & Liu, Y. (2016) · Wiley Interdisciplinary Reviews Nanomedicine and Nanobiotechnology · doi:10.1002/wnan.1410 · Cited by 83
VEGF- and VEGFR2-Targeted Liposomes for Cisplatin Delivery to Glioma Cells
Shein, S. A., Kuznetsov, I. I., Abakumova, T. O., Chelushkin, P. S., Melnikov, P., Korchagina, A. A., Bychkov, D. A., Seregina, I. F., Bolshov, M. A., Kabanov, A. V., et al. (2016) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.6b00519 · Cited by 65
Self-citationIntracellularly Swollen Polypeptide Nanogel Assists Hepatoma Chemotherapy
Shi, B., Huang, K., Ding, J., Xu, W., Yu, Y., Liu, H., Yan, L., & Chen, X. (2017) · Theranostics · doi:10.7150/thno.16794 · Cited by 55
“, micelles [7, 8], vesicles [9, 10], and nanogels [11, 12], have been prepared and used to controllably deliver many clinically important antineoplastic agents [13].”
BackgroundLHRH-peptide conjugated dextran nanoparticles for targeted delivery of cisplatin to breast cancer
Li, M., Tang, Z., Zhang, Y. X., Lv, S., Yu, H., Zhang, D., Hong, H., & Chen, X. (2014) · Journal of Materials Chemistry B · doi:10.1039/c4tb00077c · Cited by 50
Nanoparticle-mediated delivery of suicide genes in cancer therapy
Vago, R., Collico, V., Zuppone, S., Prosperi, D., & Colombo, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.07.007 · Cited by 48
Biomedical,clinical and environmental applications of platinum-based nanohybrids: An updated review
Yerpude, S. T., Potbhare, A. K., Bhilkar, P. R., Rai, A. R., Singh, R. P., Abdala, A. A., Adhikari, R., Sharma, R., & Chaudhary, R. G. (2023) · Environmental Research · doi:10.1016/j.envres.2023.116148 · Cited by 41
Conventional and new proposals of GnRH therapy for ovarian, breast, and prostatic cancers
Garrido, M. P., Hernández, A., Vega, M., Araya, E., & Romero, C. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1143261 · Cited by 35
“Ovarian cancer GnRH-nanogels with ionic cores loaded with cisplatin In vivo: ↓ Tumor volume ↑ Survival rate of animals (80)”
BackgroundInfluentialNovel Tragacanth Gum-Entrapped lecithin nanogels for anticancer drug delivery
Verma, C., Negi, P., Pathania, D., Anjum, S., & Gupta, B. (2019) · International Journal of Polymeric Materials · doi:10.1080/00914037.2019.1596910 · Cited by 32
Gupta, S., Pathak, Y. V., Gupta, M., & Vyas, S. P. (2019) · Artificial Cells Nanomedicine and Biotechnology · doi:10.1080/21691401.2019.1677680 · Cited by 31
“The LHRHnanogel cisplatin formulation was more effective and less toxic than equimolar doses of free cisplatin or untargeted nanogels in the treatment of receptor-positive ovarian cancer xenografts in mice [109].”
BackgroundRetractedPatra, P., Seesala, V. S., Das, D., Panda, A. B., Dhara, S., & Pal, S. (2018) · Polymer · doi:10.1016/j.polymer.2018.02.015 · Cited by 28
Cationic versus anionic core-shell nanogels for transport of cisplatin to lung cancer cells
González-Urías, A., Zapata‐González, I., Licea‐Claveríe, A., Licea-Navarro, A. F., Bernáldez-Sarabia, J., & Cervantes-Luévano, K. (2019) · Colloids and Surfaces B Biointerfaces · doi:10.1016/j.colsurfb.2019.110365 · Cited by 28
Formulation and evaluation of targeted nanoparticles for breast cancer theranostic system
Dadras, P., Atyabi, F., Irani, S., Ma’mani, L., Foroumadi, A., Mirzaie, Z. H., Ebrahimi, M., & Dinarvand, R. (2016) · European Journal of Pharmaceutical Sciences · doi:10.1016/j.ejps.2016.11.005 · Cited by 27
“So LHRH can be used as targeting moiety in LHRH- receptor- positive cancer cells including breast cancer for improving treatment efficiency(Li et al., 2015; Nukolova et al., 2013).”
Drug delivery for platinum therapeutics
Liu, H., Zou, J., Li, X., Ge, Y., & He, W. (2025) · Journal of Controlled Release · doi:10.1016/j.jconrel.2025.02.006 · Cited by 28
Yao, H., Xu, Z., Li, C., Tse, M., Tong, Z., & Zhu, G. (2019) · Inorganic Chemistry · doi:10.1021/acs.inorgchem.9b01583 · Cited by 25
New drug delivery strategies targeting the GnRH receptor in breast and other cancers
Ghaly, H. S. A., & Varamini, P. (2021) · Endocrine Related Cancer · doi:10.1530/erc-20-0442 · Cited by 24
Kumar, D., Moghiseh, M., Chitcholtan, K., Mutreja, I., Lowe, C., Kaushik, A. K., Butler, A. P. H., Sykes, P. H., ANDERSON, N. G., & Raja, A. Y. (2023) · Journal of Materials Chemistry B · doi:10.1039/d2tb02416k · Cited by 23
Soni, K. S., Thomas, D., Caffrey, T. C., Mehla, K., Lei, F., O’Connell, K. A., Sagar, S., Lele, S. M., Hollingsworth, M. A., Radhakrishnan, P., et al. (2019) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.118.255372 · Cited by 23
Self-citationCormier, L. E., Keeling, J. K., Rollins, J. D., Black, C. A., Collins, K., Arnold, N., Vance, D. E., & Ndinguri, M. W. (2016) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.6b00610 · Cited by 27
Analysis of montmorillonite clay as a vehicle in platinum anticancer drug delivery
Apps, M. G., Ammit, A. J., Gu, A., & Wheate, N. (2014) · Inorganica Chimica Acta · doi:10.1016/j.ica.2014.07.009 · Cited by 20
Vishwasrao, H. M., Master, А. M., Seo, Y. G., Liu, X. M., Pothayee, N., Zhou, Z., Yuan, D., Boska, M. D., Bronich, T. K., Davis, R. M., et al. (2016) · Chemistry of Materials · doi:10.1021/acs.chemmater.6b00197 · Cited by 18
Self-citationUzonwanne, V. O., Navabi, A., Obayemi, J. D., Hu, J., Salifu, A. A., Ghahremani, S., Ndahiro, N., Rahbar, N., & Soboyejo, W. O. (2022) · Biomaterials Advances · doi:10.1016/j.bioadv.2022.212801 · Cited by 17
Targeted Delivery of Cisplatin by Сonnexin 43 Vector Nanogels to the Focus of Experimental Glioma C6
Nukolova, N. V., Baklaushev, V. P., Abakumova, T. O., Melnikov, P., Abakumov, M. A., Yusubalieva, G. M., Bychkov, D. A., Kabanov, A. V., & Chekhonin, V. P. (2014) · Bulletin of Experimental Biology and Medicine · doi:10.1007/s10517-014-2606-x · Cited by 16
Self-citationGulia, M., Nishal, S., Maddiboyina, B., Dutt, R., Desu, P. K., Wadhwa, R., & Jhawat, V. (2023) · Medicine in Omics · doi:10.1016/j.meomic.2023.100020 · Cited by 16
Herbal nanogels: Revolutionizing skin cancer therapy through nanotechnology and natural remedies
Soni, S., Kori, S. K., Sahu, P. K., Kashaw, V., Dahiya, R., Iyer, A. K., Soni, V., & Kashaw, S. K. (2023) · European Journal of Medicinal Chemistry Reports · doi:10.1016/j.ejmcr.2023.100126 · Cited by 14
Preeti, Sambhakar, S., Malik, R., Bhatia, S., Al‐Harrasi, A., Saharan, R., Aggarwal, G., Kumar, S. S., Sehrawat, R., & Rani, C. (2024) · International Journal of Hypertension · doi:10.1155/2024/2430147 · Cited by 24
Li, S., Zhao, H., Chang, X., Wang, J., Zhao, E., Yin, Z., Mao, X., Deng, S., Hao, T. F., Wang, H., et al. (2018) · Journal of Peptide Science · doi:10.1002/psc.3135 · Cited by 13
“[D‐Lys(6)]‐GnRH and [Gln(1), D‐Lys(6), des‐ Gly(10), Pro(9)‐NHEt]‐GnRH (Gln‐His‐Trp‐Ser‐Tyr‐D‐Lys‐Leu‐Arg‐Pro‐ NHEt), both of which have a reactive ε‐amino group, have been used as delivery vehicles to target various diagnostic and chemotherapeutic agents to tumor cells that overexpress GnRH receptors.(12-20) The ‐cys…”
Synthesis and Evaluation of 18F-Labeled Peptide for Gonadotropin-Releasing Hormone Receptor Imaging
Huang, S., Li, H., Han, Y., Fu, L., Ren, Y., Zhang, Y., Li, Y., Sun, P., Wang, M., Wu, H., et al. (2019) · Contrast Media & Molecular Imaging · doi:10.1155/2019/5635269 · Cited by 12
Targeting Membrane Receptors of Ovarian Cancer Cells for Therapy
Liang, Z., Lu, Z., Zhang, Y., Shang, D., Li, R., Liu, L., Zhao, Z., Zhang, P., Lin, Q., Feng, C., et al. (2018) · Current Cancer Drug Targets · doi:10.2174/1568009618666181010091246 · Cited by 13
Roy, J., Kaake, M., Srinivasarao, M., & Low, P. S. (2018) · Bioconjugate Chemistry · doi:10.1021/acs.bioconjchem.8b00164 · Cited by 11
Clegg, J. R., Sun, J. A., Gu, J., Venkataraman, A. K., & Peppas, N. A. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.10.045 · Cited by 11
Polymeric Nanogels with Tailorable Degradation Behavior
Chen, Y., van Steenbergen, M. J., Li, D., van den Dikkenberg, J. B., Lammers, T., van Nostrum, C. F., Metselaar, J. M., & Hennink, W. E. (2016) · Macromolecular Bioscience · doi:10.1002/mabi.201600031 · Cited by 11
Fluorescent ABC‐Triblock Polymer Nanocarrier for Cisplatin Delivery to Cancer Cells
Kulkarni, B., Malhotra, M., & Jayakannan, M. (2022) · Chemistry - An Asian Journal · doi:10.1002/asia.202101337 · Cited by 10
Nanocarrier-mediated cancer therapy with cisplatin: A meta-analysis with a promising new paradigm
Ranasinghe, R., Mathai, M. L., Alshawsh, M. A., & Zulli, A. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e28171 · Cited by 10
Polymer-based Vehicles for Therapeutic Peptide Delivery
Zhang, J., Desale, S. S., & Bronich, T. K. (2015) · Therapeutic Delivery · doi:10.4155/tde.15.71 · Cited by 10
Self-citationHegedüs, R., Pauschert, A., Orbán, E., Szabó, I., Andreu, D., Marquardt, A., Mező, G., & Manea, M. (2015) · Biopolymers · doi:10.1002/bip.22629 · Cited by 8
Luteinizing Hormone-Releasing Hormone (LHRH)-Targeted Treatment in Ovarian Cancer
Nayak, P., Varani, M., Giorgio, A., Campagna, G., Caserta, D., & Signore, A. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms262411884 · Cited by 6
“Nanocarriers, such as liposomes, PLGA, and nanogel conjugated LHRH, have been shown to increase drug accumulation in tumors and improve treatment outcomes in both drug-sensitive and drug-resistant models [85–88].”
Multifunctional Tandem Peptide Mediates Targeted siRNA Delivery to Ovarian Cancer Cells
Alatise, K. L., Samec, T., Coffin, C., Gilmore, S. N., Hazelton, A., Xia, R., Jones, C., & Alexander-Bryant, A. A. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.4c01545 · Cited by 4
A systematic review of emerging technologies to enhance the treatment of ovarian cancer
Sepahi, S., Kiaei, L., Kiaei, M., & Ghorani‐Azam, A. (2023) · Pharmaceutical Development and Technology · doi:10.1080/10837450.2023.2233588 · Cited by 4
Vashist, A., Manickam, P., Karuppaiah, G., Alvarez, G. P., Camargo, V. A., Bhunia, S., Kolishetti, N., Raymond, A., Yndart, A., Vashist, A., et al. (2025) · ACS Applied Bio Materials · doi:10.1021/acsabm.5c00777 · Cited by 4
Cuatin, L. D. P., Zhang, D., zertuche, F., Mota, L. C., Dang, C. Y., Nayak, B., Lin, L., Brey, E. M., Noureddine, A., Kirma, N. B., et al. (2025) · Cellular and Molecular Bioengineering · doi:10.1007/s12195-025-00853-2 · Cited by 4
Cao, Y., Tong, X., Hu, W., Wang, Y., Lu, W., Chen, Y., You, J., Feng, Y., & Song, Q. (2026) · Journal of Ovarian Research · doi:10.1186/s13048-026-01964-8 · Cited by 2
“Concurrently, optimizing delivery systems (e.g., FSHR-targeted nanoparticles) is crucial for ovarian specificity and reducing off-target effects [105–107].”
Li, F., Fan, L., Li, W., Duan, X., Qiao, Y., & Wu, H. (2014) · Polymer Engineering and Science · doi:10.1002/pen.23892 · Cited by 2
Biomedical Applications of Nano-Sized Polymeric Micelles and Polyion Complexes
Alexander, K. (2018) · Journal of Siberian Federal University Biology · doi:10.17516/1997-1389-0053 · Cited by 2
“Due to the stability of such a container in the body, it is possible to address it by antibodies or other biospecific molecules attached to the container (Nukolova et al., 2011, 2013).”
BackgroundTherapeutic dosing and targeting efficacy of Pt-Mal-LHRH towards triple negative breast cancer
Ndinguri, M. W., Middleton, L. S., Unrine, J. M., Lui, S. K., Rollins, J. D., Nienaber, E., Spease, C. A., Williams, A., & Cormier, L. E. (2023) · PLoS ONE · doi:10.1371/journal.pone.0287151 · Cited by 2
Synthetic Polymer-based Nanomaterials
Desale, S. S., Zhang, J., & Bronich, T. K. (2015) · Methods in pharmacology and toxicology · doi:10.1007/978-1-4939-3121-7_1 · Cited by 2
Self-citationIdentifying nanocarrier–target interaction
Khan, S. A., Godbole, M., & Belgamwar, A. V. (2023) · Elsevier eBooks · doi:10.1016/b978-0-323-91763-6.00002-3 · Cited by 1
Nanogel-type nano-objects from a random polyelectrolyte through intermolecular cross-linking
Vardaxi, A., Foryś, A., Trzebicka, B., & Pispas, S. (2024) · Nano-Structures & Nano-Objects · doi:10.1016/j.nanoso.2024.101122 · Cited by 1
Nanotechnology advances in ovarian cancer
Patnala, K., Malla, R. R., & Vishwas, S. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822009-2.00006-6 · Cited by 1
Cormier, L. E., Black, C. A., Rollins, J. D., Overbay, B., Shiferawe, S., Elliott, A., Reitz, S., Liu, S., Li, J., Ng, C. K., et al. (2021) · ACS Omega · doi:10.1021/acsomega.0c03991 · Cited by 1
Amgoth, C., Luo, D. X., Rokkala, D., Bura, R., Bhagyalaxmi, G., Rani, R. S., Mannam, K. V., & Kothamasu, S. B. (2024) · Research Square · doi:10.21203/rs.3.rs-4147120/v1
Amgoth, C., Luo, D. X., Rokkala, D., Bura, R., Bhagyalaxmi, G., Rani, R. S., Mannam, K. V., & Babu, K. S. (2024) · Journal of Porous Materials · doi:10.1007/s10934-024-01681-x
Kumar, S., Malviya, R., Chandra, P., Sridhar, S. B., Shareef, J., Wadhwa, T., & Arockiam, D. (2026) · Journal of Nanobiotechnology · doi:10.1186/s12951-026-04788-2 · Cited by 1
“Overexpression of the LHRH-R gene has been reported in breast, endometrial, ovarian, and prostate cancers, as well as in hormone-independent malignancies including glioblastoma, pancreatic cancer, lung carcinoma, and melanoma [69–70].”
Shetty, P., Shukla, S., Phatale, V., Devi, A., Chaure, P., Srivastava, A., Khairnar, P., & Srivastava, S. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.127383
Metadata
- Authors
- Nukolova, N. V., Oberoi, H. S., Zhao, Y., Chekhonin, V. P., Kabanov, A. V., & Bronich, T. K.
- Affiliations
- Lomonosov Moscow State University (RU)
- Nebraska Medical Center (US)
- Pirogov Russian National Research Medical University (RU)
- Corresponding author
- Kabanov, Alexander V.
- Bronich, Tatiana K.
- ORCID
- Venue
- Molecular Pharmaceutics
- Publisher
- American Chemical Society (ACS)
- Published
- 2013-08-30
- Volume
- 10
- Issue
- 10
- Pages
- 3913-3921
- ISSN
- 1543-8384 (ISSN-L)
- 1543-8392
- PMC
- PMC3809768
- OpenAlex
- W2070912023
- Cited by
- 63
- References
- 32
- Citations by year
- 2026: 3 · 2025: 5 · 2024: 5 · 2023: 8 · 2022: 2 · 2021: 3 · 2020: 2 · 2019: 6 · 2018: 6 · 2017: 2 · 2016: 8 · 2015: 8 · 2014: 4 · 2013: 1
- FWCI
- 2.67
- Type
- journal article
- Language
- en
- Open access
- green
- www.ncbi.nlm.nih.gov
- Locations
- Molecular Pharmaceutics (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Cancer Institute (CA116590, R01CA116590)
- National Institute of General Medical Sciences (P20GM103480)
- National Center for Research Resources (P20RR021937)
- Topics
- Physical Sciences › Materials Science › Biomaterials › Nanoparticle-Based Drug Delivery
- Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Pharmaceutical Science › Advanced Drug Delivery Systems
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › RNA Interference and Gene Delivery
- Keywords
- nanogels, cisplatin, ovarian cancer, luteinizing hormone-releasing hormone receptor, polyethylene glycol spacer, A2780 cells, SKOV3 cells, xenografts, chemotherapy toxicity
- MeSH terms
- Nanogels, Animals, Antineoplastic Agents, Cisplatin, Female, Flow Cytometry, Humans, Mice, Nude, Ovarian Neoplasms, Polyethylene Glycols, Polyethyleneimine, Drug Delivery Systems, Microscopy, Confocal, Cell Line, Tumor, Nanoparticles
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.